Launched under the brand name FabiFlu, the oral drug will be available as a prescription-based medication for US$1.35 per tablet.
It offers rapid reduction in viral load within four days and has shown clinical improvement of up to 88 per cent in mild to moderate Covid-19 cases, it added. In another development, a gunfight between militants and government forces broke out Sunday in restive Indian-controlled Kashmir, police said."A gunfight started between militants and joint contingents of police and paramilitary at Zadibal-Soura area of the city early today," a police spokesman said."The stand-off is underway."